Abstract Details

Title Clinical Trial and Post-marketing Reports Indicate No Increased Risk of Herpes Zoster in Patients Treated With Delayed-release Dimethyl Fumarate

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 362

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Jerome Hanna PRESENTER	No disclosure on file
Claudia Prada	No disclosure on file
Nicholas J. Everage	No disclosure on file
Sirisha Kalari	No disclosure on file
Spyridon Chalkias, MD (Biogen)	Dr. Chalkias has received personal compensation for serving as an employee of Biogen.
	No disclosure on file
Karen Smirnakis	No disclosure on file
	No disclosure on file